May 5th, 2014|
Endo International, PLC reports that it has agreed to settle “a substantial majority” of lawsuits brought against its subsidiary, American Medical Systems Inc. (“AMS”), for producing allegedly harmful vaginal mesh products used to treat feminine stress urinary incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).
Endo’s settlements will resolve approximately 20,000 claims that have been filed against the company. Most of these claims have been coordinated in a multidistrict litigation (“MDL”) in front of Hon. Joseph R. Goodwin in the U.S. District Court for the Southern District of West Virginia, while other individual claims have also been filed in various state and Canadian courts.
The lawsuits allege that AMS’s vaginal mesh devices are defective, causing the plaintiffs chronic pain, incontinence, permanent nerve damage, vaginal erosions, organ injury, and numerous other health problems.
Plaintiffs’ attorneys estimate that this most recent settlement will be implemented over the next year. Endo, who settled an unspecified number of vaginal mesh claims in June 2013 for $54.5 million, had originally allocated approximately $520 million to cover settlement costs for defective mesh lawsuits. Despite the settlement, Endo has not admitted liability or fault.
Along with the 20,000 settling claims against Endo for its AMS vaginal meshes, there are also still over 40,000 other pending lawsuits against Johnson & Johnson, C.R. Bard, and Boston Scientific Corp. for complications caused by their own vaginal mesh devices.
To date, several multi-million dollar jury verdicts have been awarded to the women who have alleged they were harmed by devices made by non-settling defendant companies and additional trials are already scheduled to continue for the next 18 months.